跳至主要内容
临床试验/JPRN-UMIN000041659
JPRN-UMIN000041659尚未招募未知

The significance of changes in tumor hypoxia by anti-PD-1 / PD-L1 antibody therapy for advanced non-small cell lung cancer. - Hypoxia and immunotherapy in lung cancer

Saitama Medical University International Medical Center0 个研究点目标入组 20 人开始时间: 2020年9月3日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Pregnant women, lactating women and women with the possibility or intention of becoming pregnant 2. Patients with complications that require intravenous administration of antibiotics and antifungal agents 3.Patients who need to administer systemic steroids and other immunosuppressive drugs 4. Patients with diabetes 5. In addition, patients who are judged as inappropriate by the doctor's judgment

研究者

相似试验

The significance of changes in tumor hypoxia by... | 临床试验